At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Customized Scleral Lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus
In Brief
A clinical study evaluating Customized Scleral Lens for Keratoconus. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ectasia, who have already been fitted with the BostonSight BSS (Boston Sight Scleral) for improved visual function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKeratoconus
CountriesUnited States
CollaboratorsOvitz Corporation, Boston Sight
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartOct 2018
Primary CompletionJan 2020
TodayJul 2026
First PostedAug 27, 2018
Enrollment StartOct 8, 2018
Primary CompletionJan 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.8 years ago
Interventions
Customized Scleral Lensdevice
A wavefront customized scleral lens will be made for each subject and tested against a non-customized lens.